Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 4/10/2024
Clinical infectious diseases
Date: 05 2016
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
World Journal of hepatology
Volume: 8(31)
Date: 11 2016
Expansion of treatmen tfor hepatitis C virus infection by task shifting to community-based nonspecialist providers: a non-randomized clinical trial
Annals of Internal Medicine
Volume: 167(5)
Date: 09 2017
Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population.
Journal of Viral hepatology
Date: 10 2017
Hepatitis B Virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis
Lancet Gastroenterology and Hepatology
Date: 01 2018
Chronic Hepatitis B Infection: A Review
JAMA
Volume: 319
Date: 05 2018
Follicular Helper T (TFH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients
Frontiers in Immunology
Date: 08 2021
CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients.
Viruses
Volume: 13
Date: 10 2021
Programmed death 1 expressing CD8 + CXCR5 + follicular T cells constitute effector rather than exhaustive phenotype in patients with chronic hepatitis B.
Hepatology
Date: 10 2021
pubmed.ncbi.nlm.nih.gov/34689344/
Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression
Journal of Hepatology
Volume: 78
Date: 03 2023
www.sciencedirect.com/science/article/pii/S0168827822031488?via%3Dihub
